Hepatitis C resistance to NS5A inhibitors:Is it going to be a problem?

• 作 者: Heidar Sharafi Seyed Moayed Al
• 机 构: BaqiyatallahResearchCenterforGastroenterologyandLiverDiseases,MiddleEastLiverDiseasesCenter
• 出 处: 世界肝病学杂志：英文版（电子版）
• 发表日期: 2018年9期
• 关键词: Direct-acting ANTIVIRAL agent Hepatitis C NS5A RESISTANCE Treatment

Treatment of hepatitis C virus(HCV)infection has evolved greatly through the recent decade.The availability of direct-acting antiviral agents(DAAs)targeting the functional proteins of HCV has resulted in the introduction of DAA-based combination therapies